Aslan
ClosedSingapore, Singapore · Founded 2010 · $76.0M raised
- Headquarters
- Singapore
- Employees
- 11–50
- Founded
- 2010
- Business Model
- B2B
- Website
- aslanpharma.com
- Total Funding
- $76.0M
- Last Round
- $20.0M Venture RoundMar 2023
- Rounds
- 5
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 6 funding rounds for this company. The full record is or through the API.
About
ASLAN Pharmaceuticals is a Singapore-based clinical-stage biopharmaceutical company developing immunotherapies and targeted agents for indications including atopic dermatitis and autoimmune conditions. Its lead candidate, eblasakimab, is an antibody targeting the IL-13 receptor. Founded in 2010 by Carl Firth, ASLAN listed on Nasdaq in 2018 and has raised capital across venture, pre-IPO and post-IPO rounds from investors such as Accuron Technologies (a Temasek subsidiary), BVF Partners and K2 HealthVentures.
Summary
Aslan is a Biotech company based in Singapore, Singapore, founded in 2010. It has raised $76.0M in total across 5 rounds, most recently a $20.0M Venture Round in Mar 2023.
Funding & Exit History
Mar 2023
Sign up to see all 6 events
Funding: Seed through Venture Round. Amounts, valuations, and investors where available.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aslan"><img src="https://indexed.vc/api/badge/company/aslan" alt="Aslan on Indexed.vc" width="260" height="76" /></a>